Company intelligence / Profile preview

DexaFit

United States

Ownership: Private
Development stage: Other

Overview

DexaFit operates a commercial health diagnostics and analytics platform using DEXA scans, VO2 Max testing, RMR analysis, and biomarker/lab testing to provide personalized metabolic, physiological, and fitness insights for preventive and wellness-focused care. Clinical outcomes are evidenced by user-reported improvements in health tracking and risk reduction but not by disease treatment or intervention endpoints.[1][5][7][8]

Therapeutic areas: CardiovascularEndocrinologyGastroenterologyMetabolic DisordersOther
Modalities: DeviceBiomarker analysisDNA analysisDigital health platform
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Licensed independent operators across US locationsResearch and academic collaborators for de-identified data sharing

Beyond the preview

Go deeper on DexaFit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DexaFit.

Explore the full profile